Addressing Process Deviations in Manufacturing

𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗖𝗔𝗣𝗔: A Powerful Tool for Sustainable Quality Improvement In any manufacturing, product quality and consistency are critical. But despite best efforts, issues do occur — a deviation in production, a packaging defect, or a market complaint. This is when 𝗖𝗔𝗣𝗔 becomes more than just a process — it becomes a commitment to continuous improvement. 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗖𝗔𝗣𝗔? 𝗖𝗔𝗣𝗔 stands for Corrective and Preventive Action — a systematic method to: • Identify the root cause of a problem • Take actions to fix it • Prevent it from happening again It’s a key component of any robust Quality Management System (𝗤𝗠𝗦) and essential for operational excellence. 𝗪𝗵𝘆 𝗶𝘀 𝗖𝗔𝗣𝗔 𝗖𝗿𝗶𝘁𝗶𝗰𝗮𝗹? • Ensures product quality and consumer safety • Reduces recurring issues and production downtime • Supports regulatory and certification compliance (ISO, BRC, FDA, etc.) • Enhances team accountability and cross-functional learning • Builds long-term trust with consumers and stakeholders 𝗧𝗵𝗲 𝗖𝗔𝗣𝗔 𝗣𝗿𝗼𝗰𝗲𝘀𝘀: 𝗦𝘁𝗲𝗽 𝗯𝘆 𝗦𝘁𝗲𝗽 𝟭. 𝗣𝗿𝗼𝗯𝗹𝗲𝗺 𝗜𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 • Receive and log the issue (complaint, audit non-conformance, or deviation). • Understand where, when, and how it was discovered. 𝟮. 𝗖𝗼𝗿𝗿𝗲𝗰𝘁𝗶𝗼𝗻 (𝗜𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗔𝗰𝘁𝗶𝗼𝗻) • Isolate the affected product or batch. • Inform relevant stakeholders and prevent further distribution. 𝟯. 𝗥𝗼𝗼𝘁 𝗖𝗮𝘂𝘀𝗲 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 • Use structured tools: 5 Whys, Fishbone Diagram, Pareto Analysis • Focus on identifying the true systemic issue, not just symptoms. 𝟰. 𝗖𝗼𝗿𝗿𝗲𝗰𝘁𝗶𝘃𝗲 𝗔𝗰𝘁𝗶𝗼𝗻𝘀 • Implement targeted solutions to eliminate the root cause. • Examples: process change, retraining, equipment upgrade, supplier improvement. 𝟱. 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝘃𝗲 𝗔𝗰𝘁𝗶𝗼𝗻𝘀 • Assess risk across related areas. • Strengthen controls, modify SOPs, or introduce new checks to stop similar issues elsewhere. 𝟲. 𝗘𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀 𝗖𝗵𝗲𝗰𝗸 • Track KPIs and monitor trends. • Audit the implemented changes and ensure sustainability of results. 𝟳. 𝗗𝗼𝗰𝘂𝗺𝗲𝗻𝘁 𝗘𝘃𝗲𝗿𝘆𝘁𝗵𝗶𝗻𝗴 • Record all findings, actions, and decisions. • Good documentation ensures traceability and supports future audits or reviews. 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗘𝘅𝗮𝗺𝗽𝗹𝗲: A detergent pouch was reported leaking in distribution: • Correction: Recalled affected pouches and halted dispatch. • Root Cause Analysis: Identified sealing temperature inconsistency due to worn-out heating elements. • Corrective Action: Replaced machine components and retrained operators. • Preventive Action: Introduced new validation steps before every shift and added an automated sealing sensor. • Verification: No leakage reported in 3 months of follow-up data. #CAPA #QualityManagement #FMCG #Manufacturing #Compliance #RootCauseAnalysis #ContinuousImprovement #OperationalExcellence #QMS #ProblemSolving #AuditReady

Is “Operator Error” the Real Root Cause in Manufacturing? When a defect, breakdown, or safety incident happens on the shop floor, many investigations quickly settle on one conclusion: “operator error.” It’s simple, fast, and seems to explain everything. But in modern manufacturing, this label is often a symptom of deeper issues, not the real cause. Behind every so-called “human error” there is usually a chain of factors: 1.Inadequate or unclear work instructions 2.Poor workstation ergonomics or excessive fatigue 3.Gaps in training or skill development 4.Lack of mistake-proofing (Poka-Yoke) in process design 5.Equipment not calibrated, or preventive maintenance overdue 6.Material inconsistency, environment fluctuations, or unrealistic production targets Blaming people may give temporary closure but blocks true continuous improvement. A blame culture discourages operators from reporting near misses or improvement ideas — leading to recurring failures, higher costs, and low morale. The best manufacturing organizations take a systemic approach: • Use structured root-cause tools (5 Why, Fishbone/Ishikawa, FMEA) • Build strong SOPs and visual standards • Error-proof high-risk activities wherever possible • Create an open environment where operators, engineers, and leaders solve problems together When teams stop asking “Who messed up?” and start asking “What in our process allowed this to happen?”, quality, safety, and productivity all improve. #ManufacturingExcellence #RootCauseAnalysis #LeanManufacturing #Qualitycircle

“Quality Matters in Deviations, Not in Incidents”...... 1. Deviation ✅ (Quality Parameter) Definition: A deviation is any planned or unplanned departure from approved instructions, specifications, SOPs, or GMP requirements. Why a Quality Parameter: It is directly linked to product quality and patient safety. Must be assessed under the Pharmaceutical Quality System (PQS). Handling: Requires investigation, root cause analysis, and CAPA. Guideline References: ICH Q10 (Pharmaceutical Quality System): Deviation management is part of CAPA system. EU GMP Chapter 1: All deviations must be recorded, investigated, and evaluated for product quality impact. US FDA 21 CFR Part 211.100(b): Significant deviations from written procedures must be recorded and justified. Examples: OOS (Out of Specification) result. Equipment not calibrated but used. Tablet hardness outside limit. 2. Incident ❌ (Not a Quality Parameter) Definition: An incident is an unexpected event that occurs during routine operations, but does not necessarily impact product quality or GMP compliance. Why Not a Quality Parameter: Incidents are more related to safety, environment, or operational issues, not product release decisions. Handling: Logged, reviewed, preventive action may be taken, but not evaluated as a PQS quality deviation. Guideline References: WHO GMP Annex 3 (2022): Incident reporting for occupational, environmental, or facility-related events. EHS (Environment, Health & Safety) Regulations: Incidents fall under safety management rather than quality system. Examples: Short power failure (no effect on product). Water leakage in warehouse corridor. HVAC breakdown in non-critical area. ✅ Summary: Deviation = Always linked to product quality & GMP → handled under PQS with CAPA. Incident = Event not directly affecting quality → handled under EHS or facility management systems.

✅ Deviation Classification Interview Q&A Q1: What are the types of deviations in the pharmaceutical industry? Answer: Deviations are classified as: 1. Incidents – Unplanned events with no GMP breach and no product/process risk. Action: Document and monitor. 2. Minor Deviations – GMP deviation with no impact on quality, safety, or compliance. Example: wrong pen color. 3. Major Deviations – Potential impact on quality, process integrity, or regulatory compliance. Example: missed IPC. 4. Critical Deviations – Actual or high risk to product quality or patient safety. Example: skipped manufacturing step, data falsification. Q2: How do you determine the severity of a deviation? Answer: Severity is determined by assessing the: Impact on product quality Process integrity Patient safety Compliance with GMP Tools like Risk Assessment Matrix and Impact Assessment Checklists are used. Q3: What is the difference between a critical and a major deviation? Answer: Major: Has potential impact; needs investigation and CAPA. Critical: Has actual impact or high risk to patient safety, data integrity, or product release; requires immediate escalation, regulatory involvement, and possibly batch rejection. ✅ Deviation Lifecycle Interview Q&A Q4: What are the steps in the deviation lifecycle? Answer: 1. Detection – Identification of deviation. 2. Documentation – Logging into QMS/logbook. 3. Impact Assessment – Evaluating risk to quality, safety, compliance. 4. Investigation – Root Cause Analysis (RCA). 5. CAPA – Corrective and Preventive Actions. 6. QA Review – Verification by QA. 7. Closure – Final justification and closure. 8. Trending – Analysis for system improvement. Q5: What is RCA in deviation management? Answer: RCA stands for Root Cause Analysis, a structured method to identify the true cause of deviation. Tools used: 5 Whys Fishbone Diagram (Ishikawa) FMEA (Failure Mode Effect Analysis) Q6: What are ALCOA++ principles in deviation closure? Answer: ALCOA++ refers to data integrity principles: Attributable Legible Contemporaneous Original Accurate And extended with: Complete, Consistent, Enduring, and Available Q7: What actions are taken in CAPA? Answer: Corrective Actions: Fix the existing deviation. Preventive Actions: Prevent recurrence by modifying process, training, or SOP. Q8: What is deviation trending and why is it important? Answer: Trending involves analyzing multiple deviations to: Identify recurring issues Recognize systemic gaps Drive continuous quality improvement Trending data is used for management review and audit readiness.

🚫⚠️ GXP VIOLATIONS- Part II: Why is "Closing Deviations Without a True Root Cause" a Major FDA Red Flag? 🚨 In #pharmaceutical and #meddev manufacturing, the integrity of your #QualitySystem hinges on how you handle #Deviations. Yet, we still see the dangerous shortcut: closing deviations with vague or insufficient #RootCauseAnalysis (RCA) or labeling them as #HumanError without deeper investigation. This practice is explicitly targeted by the FDA and undermines the entire #CGMP framework. 🔍 Why Is It So Problematic❓ ❌ Systemic Failure: Pinning a deviation on simple "Human Error" or "Procedural Non-Adherence" without investigating why the error occurred means the systemic weakness remains. The same deviation will happen again. 📉 Regulatory Non-Compliance: FDA inspectors look for robust, data-driven RCA. A pattern of weak investigations signals a fundamental flaw in your #QualityCulture and your ability to control processes. 🧬 Process Drift: If the true cause isn't addressed, your process control will degrade over time, leading to product quality issues. 🚫 Ineffective CAPA: A poor RCA leads to a poor #CAPA. If you don't know the real problem, you can't fix it effectively. This is a common #WarningLetter theme. ✅ What Does the FDA Expect? 🔎 Investigate the 'Why': Move beyond the "What" (the deviation itself) and the "Who" (the operator) to find the True Root Cause. 📚 Systemic Focus: Ask: Was the procedure clear ❓ Was the training adequate❓ Was the equipment suitable❓ Does the workflow encourage errors❓ 👀Systems, not just people, fail‼️ ✍️ Documentation Rigor: All investigative steps, interviews, data reviewed, and scientific justifications for the chosen root cause must be meticulously documented and approved by #QualityAssurance. 📈 Verify CAPA Effectiveness: The investigation isn't over when the CAPA is implemented. You must have a follow-up plan to verify that the CAPA permanently eliminated the deviation's recurrence. ⚠️ Consequences of Weak Investigations 🕵️♂️ Repeat Observations: Inspectors will note repeat deviations and cite your investigation system as inadequate. 📉 Regulatory Escalation: Warning letters and enforcement actions often cite a lack of timely and effective investigation of deviations. 💊 Risk to Product Quality: Allowing systemic problems to persist puts the safety, identity, strength, purity, and quality (SISPQ) of your product at risk. 📚 Essential Regulatory References 1. FDA Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations 2. FDA Guidance for Industry: Data Integrity and Compliance With Drug CGMP 🫵 If you work in #GxP and understand the importance of a true Root Cause Analysis, share this post with your network and follow me on LinkedIn 👇 https://lnkd.in/dSUvn86V #Compliance #FDA #GMP #GXP #Pharmaceutical #MedicalDevices #RegulatoryAffairs #RiskManagement #Manufacturing #DataIntegrity #CAPA #QualityCulture

🚨 Running Through Problems Isn’t Efficiency — It’s Denial. It’s easy to fix a problem and keep the line running. It’s hard to stop, call for help, and understand why it happened. But that’s exactly what separates reactionary operations from robust systems. As humans, we’re wired to solve. We adjust, patch, and move on — because stopping production feels wrong. But every time we “fix and run,” we’re silently teaching the organization that output matters more than understanding. And that mindset is what kills long-term performance. 🔎 Under a mature Quality Management System — stopping for abnormal conditions isn’t optional. IT'S A REQUIREMENT! Every time a team member sees something off — missing tools, unclear instructions, recurring alarms, process deviations — that’s not just a nuisance. That’s a signal. An early warning that risk has entered the process. Ignoring that signal doesn’t save time — it delays the inevitable failure. 🧭 So how do we change the culture? It starts with leadership. Leaders must create an environment where “stop and escalate” is safe and expected. Not punished — celebrated. Train your Team Leaders and Supervisors to: ✅ Recognize abnormal conditions and pull the Andon (or equivalent). ✅ React within the escalation process — not outside it. ✅ Document what happened in the problem-solving system (8D, QRQC, etc.). ✅ Follow through with cross-functional closure — maintenance, engineering, and quality validating countermeasures. Because risk-based thinking means more than filling out forms — it means acting when the risk appears, not after the damage is done. Every uninvestigated abnormality is an uncontrolled risk. Stopping isn’t weakness. It’s discipline. It’s leadership. And it’s how true quality organizations earn the right to run. #Quality #Leadership #Manufacturing #IATF16949 #ContinuousImprovement #ProblemSolving #LeanThinking #CultureOfQuality #ProcessDiscipline #RootCause

Steps to Handle and Prevent Deviations: 1. Immediate Action: Stop the process (if needed) to prevent further impact. Document the deviation clearly and completely. 2. Deviation Report: Include date, time, description, affected batch/product, personnel involved, etc. 3. Root Cause Analysis (RCA): Use tools like 5 Whys, Fishbone (Ishikawa) diagram, or FMEA to identify the root cause. 4. Corrective and Preventive Actions (CAPA): Corrective Actions: Fix the current problem (e.g., retraining, equipment repair). Preventive Actions: Prevent future recurrence (e.g., SOP revision, automation, error-proofing). 5. Training: Retrain employees on procedures and GMP. Emphasize awareness of quality culture. 6. Monitoring and Review: Track deviation trends regularly. Perform audits to ensure CAPAs are effective.

💭 “If defects are not free… why do organizations still treat them as unavoidable?” As quoted by W. Edwards Deming: “Defects are not free. Somebody makes them, and gets paid for making them.” It sounds simple. Almost obvious. But the deeper you reflect, the more uncomfortable the truth becomes. For example, Imagine a machining line producing components with recurring dimensional deviations. The team had become so used to the issue that rework stations were permanently staffed. The justification given: 👉 “Rework is faster than fixing the process.” The organization wasn’t just tolerating defects… it was structurally funding them — paying for extra manpower, inspection, delays, customer complaints, and reputation risk. 🔧 Manufacturing Reality Check In manufacturing, defects silently multiply costs through: • Rework and scrap • Line stoppages and productivity loss • Warranty failures and field complaints • Excess inspection and firefighting culture • Loss of customer trust Toyota calls this “hidden factory” — the parallel system running only to correct mistakes that should never have occurred. World-class organizations don’t invest in detecting defects. They invest in designing processes where defects struggle to survive. 🏨 Service Industry Is No Different Consider a banking or insurance service process. A single data entry error in customer onboarding can trigger: • Multiple follow-up calls • Compliance risks • Customer dissatisfaction • Brand erosion • Additional operational cost Or take healthcare — a missing documentation detail can lead to delayed treatment, billing disputes, or patient safety risks. Service defects may not create scrap material… but they create scrap experiences. 📖 The Real Story Behind Quality Deming’s philosophy wasn’t about catching people making mistakes. It was about asking: ➡ Why does the system allow mistakes to happen? ➡ What conditions are pushing good employees to produce bad outcomes? ➡ Are we rewarding speed more than stability and consistency? Because most defects are not created by people… They are created by process design, management priorities, and system thinking gaps. 💡The Leadership Question Organizations serious about operational excellence must shift from: ❌ “Who made the mistake?” to ✅ “What allowed the mistake to occur repeatedly?” When prevention becomes culture, quality stops being a department… and becomes a competitive advantage. Deming said it decades ago. Yet it remains one of the most expensive lessons industries continue to relearn. 👉 How does your organization handle defects — fixing them or preventing them? Would love to hear your experiences. 📷 Image Credit: Quote by W. Edwards Deming (Image sourced from public domain) #Quality #OperationalExcellence #LeanManufacturing #TQM #Deming #ContinuousImprovement #Monozukuri #CustomerExperience #ServiceExcellence #ManufacturingLeadership #ProcessImprovement #QualityCulture